These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 21204710)

  • 1. Multiparameter flow cytometry in the diagnosis and management of acute leukemia.
    Peters JM; Ansari MQ
    Arch Pathol Lab Med; 2011 Jan; 135(1):44-54. PubMed ID: 21204710
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flow cytometric analysis of acute leukemias. Diagnostic utility and critical analysis of data.
    Kaleem Z; Crawford E; Pathan MH; Jasper L; Covinsky MA; Johnson LR; White G
    Arch Pathol Lab Med; 2003 Jan; 127(1):42-8. PubMed ID: 12521365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy.
    Digiuseppe JA
    Clin Lab Med; 2007 Sep; 27(3):533-49, vi. PubMed ID: 17658406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry in the diagnosis of acute leukemia.
    Weir EG; Borowitz MJ
    Semin Hematol; 2001 Apr; 38(2):124-38. PubMed ID: 11309694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping by Multiparameter Flow Cytometry.
    Chen W; Luu HS
    Methods Mol Biol; 2017; 1633():51-73. PubMed ID: 28735480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunophenotyping of acute leukemias: diagnostic and pronostic utility in Abidjan, Côte d'Ivoire].
    Inwoley KA; Sawadogo D; Mizero L; Salou M; Karim N; Sangaré A
    Bull Soc Pathol Exot; 2004; 97(5):319-22. PubMed ID: 15787262
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in Acute Myeloid Leukemia Classification, Prognostication and Monitoring by Flow Cytometry.
    Lucas F; Hergott CB
    Clin Lab Med; 2023 Sep; 43(3):377-398. PubMed ID: 37481318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Detection of minimal residual disease in acute leukemias by flow cytometry].
    Scolnik MP
    Medicina (B Aires); 2000; 60 Suppl 2():83-6. PubMed ID: 11188938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
    Rothe G; Schmitz G
    Leukemia; 1996 May; 10(5):877-95. PubMed ID: 8656686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of immunophenotyping on management of acute leukemias.
    Béné MC; Bernier M; Castoldi G; Faure GC; Knapp W; Ludwig WD; Matutes E; Orfao A; van't Veer M
    Haematologica; 1999 Nov; 84(11):1024-34. PubMed ID: 10553164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of CD45/SSC gating multiparameter flow cytometry in the classification of acute leukemia--an analysis of 139 cases.
    Li W; Chen Z; Liu Z; Zou P
    J Tongji Med Univ; 2001; 21(3):209-11. PubMed ID: 12539578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First proposed panels on acute leukemia for four-color immunophenotyping by flow cytometry from the Brazilian group of flow cytometry-GBCFLUX.
    Ikoma MR; Sandes AF; Thiago LS; Cavalcanti Júnior GB; Lorand-Metze IG; Costa ES; Pimenta G; Santos-Silva MC; Bacal NS; Yamamoto M; Souto EX;
    Cytometry B Clin Cytom; 2015; 88(3):194-203. PubMed ID: 24753208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flow cytometric monitoring of residual disease in acute leukemia.
    Wood BL
    Methods Mol Biol; 2013; 999():123-36. PubMed ID: 23666694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Leukemias of indeterminant lineage.
    Lee EJ; Schiffer CA
    Clin Lab Med; 1990 Dec; 10(4):737-54. PubMed ID: 2272172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute Myeloid Leukemia Immunophenotyping by Flow Cytometric Analysis.
    Chen X; Cherian S
    Clin Lab Med; 2017 Dec; 37(4):753-769. PubMed ID: 29128067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flow cytometric characterization of acute myeloid leukemia. Part 1. Significance of light scattering properties.
    Terstappen LW; Könemann S; Safford M; Loken MR; Zurlutter K; Büchner T; Hiddemann W; Wörmann B
    Leukemia; 1991 Apr; 5(4):315-21. PubMed ID: 2027298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New methodologic approaches for immunophenotyping acute leukemias.
    Basso G; Buldini B; De Zen L; Orfao A
    Haematologica; 2001 Jul; 86(7):675-92. PubMed ID: 11454522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies in the management of acute leukemia.
    Wang JC; Beauregard P; Soamboonsrup P; Neame PB
    Am J Hematol; 1995 Nov; 50(3):188-99. PubMed ID: 7485080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal residual disease in adolescent (older than 14 years) and adult acute lymphoblastic leukemias: early immunophenotypic evaluation has high clinical value.
    Vidriales MB; Pérez JJ; López-Berges MC; Gutiérrez N; Ciudad J; Lucio P; Vazquez L; García-Sanz R; del Cañizo MC; Fernández-Calvo J; Ramos F; Rodríguez MJ; Calmuntia MJ; Porwith A; Orfao A; San-Miguel JF
    Blood; 2003 Jun; 101(12):4695-700. PubMed ID: 12586618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational analysis of flow-cytometry antigen expression profiles in childhood acute lymphoblastic leukemia: an MLL/AF4 identification.
    De Zen L; Bicciato S; te Kronnie G; Basso G
    Leukemia; 2003 Aug; 17(8):1557-65. PubMed ID: 12886243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.